Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksABAL.L Regulatory News (ABAL)

  • There is currently no data for ABAL

Contract Win

8 Jul 2013 07:00

RNS Number : 7382I
Imaginatik PLC
08 July 2013
 



8 July 2013

 

Imaginatik Plc

("Imaginatik" or the "Company")

Contract Win

 

Imaginatik plc (AIM: IMTK.L), the world's first full service innovation provider offering a range of technology products and consultancy, is pleased to announce that a long-term US based client in the financial services sector has agreed an extended two year contract worth in excess of £0.7 million effective as of September 2013. Under the Company's new revenue recognition policy, approximately £0.2m of this contract is expected to be recognised in the current financial year, with the remainder adding to Imaginatik's growing level of deferred contracted revenue.

Matt Cooper, Executive Chairman of Imaginatik, commented: "We are delighted by this significant endorsement of the value of our innovation services by a long-standing customer following compelling levels of returns on investment from our services. This contract sees the extension of our innovation platform to incorporate users who are external to the customer, enabling them to participate in challenges that will drive further substantial benefits to the client. With innovation moving up the corporate agenda and a growing market awareness of the strength of our comprehensive offering, we are confident of Imaginatik's success."

For further information please contact:

 

Imaginatik plc

Tel: 020 7917 2975

Matt Cooper, Executive Chairman / Shawn Taylor, CFO

finnCap Ltd

Tel: 020 7220 0500

Charlotte Stranner/ Victoria Bates

Newgate Threadneedle

Tel: 020 7653 9850

Caroline Evans-Jones / Hilary Millar

 

About Imaginatik

 

Imaginatik® is the world's first full-service innovation firm. We have 16 years of experience building innovation into a sustainable competence at some of the world's largest and most respected companies. Through a mix of consulting and advisory, hands-on innovation projects and program management, and our award-winning enterprise software platform, we help clients develop innovation capability into a permanent competitive advantage. Imaginatik is the trusted partner of leading organizations including Blue Cross Blue Shield, CSC, Cargill, The World Bank, Exxon Mobil, Mayo Clinic, The Chubb Group of Insurance Companies, HCA, Dow Chemical and Goodyear.

Imaginatik is a public company whose shares are traded on the AIM market of the London Stock Exchange (LSE:IMTK.L) and is a World Economic Forum Technology Pioneer with offices in Boston, MA, and Fareham, UK. For more information visit www.imaginatik.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTBSGDRSGGBGXU
Date   Source Headline
15th Jun 20107:00 amRNSAppointment of Chief Operating Officer
1st Jun 20103:48 pmRNSHolding(s) in Company
13th May 20107:00 amRNSAppointment of Interim Vice President of Sales
6th May 20102:11 pmRNSHolding(s) in Company
28th Apr 20107:00 amRNSTrading Update
10th Mar 20107:00 amRNSDirector/PDMR Shareholding
4th Mar 20107:00 amRNSTrading Update
22nd Feb 20107:00 amRNSWindsor Foods Selects Imaginatik
17th Feb 20109:45 amRNSDirector Shareholding
29th Jan 201011:41 amRNSContract Win
22nd Dec 20097:00 amRNSDirectorate Change
17th Dec 20097:00 amRNSContract Win with Global Consumer Products Company
11th Dec 20097:00 amRNSContract Extension
17th Nov 20097:00 amRNSInterim Results
13th Nov 20097:00 amRNSContract Win
12th Nov 20097:00 amRNSNotice of Results
9th Oct 20097:00 amRNSTrading Update & Directorate Change
2nd Oct 20097:00 amRNSContract Win with global technology business
28th Sep 20097:00 amRNSContract Win with US Insurer
24th Sep 20097:00 amRNSDirector/PDMR Shareholding
23rd Sep 20097:00 amRNSProduct Launch
10th Sep 20097:00 amRNSContract Win
8th Sep 20097:00 amRNSWorld Economic Forum
13th Aug 20094:26 pmRNSHolding(s) in Company
13th Aug 20093:00 pmRNSHolding(s) in Company
13th Aug 200911:18 amRNSDirector/PDMR Shareholding
12th Aug 20095:17 pmRNSAdditional Listing
10th Aug 20097:00 amRNSPlacing
28th Jul 20097:00 amRNSAGM Statement
3rd Jul 20092:21 pmRNSDirector/PDMR - Share Subscription
29th Jun 20092:34 pmRNSAnnual Report & Accounts
17th Jun 20097:00 amRNSFinal Results
2nd Jun 20097:00 amRNSChange of Adviser & Notice of Results
15th May 200910:33 amRNSDirectorate Change
3rd Apr 20097:00 amRNSContract Win & Trading Update
19th Mar 20097:00 amRNSContract Extension with Chubb
5th Feb 20097:00 amRNSManagement Appointment
23rd Jan 20094:30 pmRNSDirector/PDMR Shareholding
23rd Jan 20097:00 amRNSWorld Economic Forum
15th Jan 20097:00 amRNSTrading on PLUS
14th Jan 20093:10 pmRNSDirector/PDMR Shareholding
14th Jan 20097:00 amRNSPharmaceutical Contract Win
9th Jan 20099:09 amRNSDirector/PDMR Shareholding
7th Jan 20091:35 pmRNSDirector/PDMR Shareholding
5th Jan 200911:10 amRNSDirector/PDMR Shareholding
5th Jan 20099:40 amRNSDirector/PDMR Shareholding
2nd Jan 20099:05 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSDirector/PDMR Shareholding
31st Dec 20087:00 amRNSTotal Voting Rights
24th Dec 200810:48 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.